Dr. Inman Discusses the Biology of Bladder Cancer

Brant Inman, MD
Published: Tuesday, Oct 03, 2017



Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the biology of bladder cancer.

Bladder cancer is being better understood with the utilization of genome sequencing and RNA sequencing, both of which have allowed for this disease to be categorized into several different molecular subtypes.

Tests to check for these subtypes will become important in the future, Inman says, as it will help guide treatment for patients.
 


Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the biology of bladder cancer.

Bladder cancer is being better understood with the utilization of genome sequencing and RNA sequencing, both of which have allowed for this disease to be categorized into several different molecular subtypes.

Tests to check for these subtypes will become important in the future, Inman says, as it will help guide treatment for patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x